[Effect of long-term therapy with sulfanylurea preparations on the relation of insulin secretion and the insulin-binding capacity of its receptors].
Balabolkin
M I
MI
Nedosugova
L V
LV
D001786:Blood Glucose / Q000032:analysis; D002747:Chlorpropamide / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000378:metabolism; D004341:Drug Evaluation; D005260:Female; D005907:Gliclazide / Q000627:therapeutic use; D005951:Glucose Tolerance Test; D005905:Glyburide / Q000627:therapeutic use; D006029:Glycosuria / Q000652:urine; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism*; D007330:Insulin Antibodies / Q000032:analysis; D000078790:Insulin Secretion; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011972:Receptor, Insulin / Q000187:drug effects* / Q000378:metabolism; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D007330:Insulin Antibodies; D013453:Sulfonylurea Compounds; D011972:Receptor, Insulin; D005907:Gliclazide; D005905:Glyburide; D002747:Chlorpropamide
Vliianie dlitel'noĭ terapii preparatami sul'fanilmocheviny na otnosheniia mezhdu sekretsieĭ insulina i insulinsviazyvaiushcheĭ sposobnost'iu ego retseptorov.